Risk factors for hospitalization for respiratory syncytial virus infection

Pediatric Infectious Disease Journal

Volumn 35, Issue 1, 2016, Pages 61-65

  Haerskjold, Ann ^a   Kristensen, Kim ^b   Kamper Jørgensen, Mads ^c   Nybo Andersen, Anne Marie ^c   Ravn, Henrik ^d   Graff Stensballe, Lone ^a  

^a Rigshospitalet   (Denmark)

^b Naestved University Hospital   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d University of Copenhagen ^*  (Denmark)

Author keywords

children; hospitalization; respiratory syncytial virus; risk factors

Indexed keywords

ARTICLE; ASTHMA; CESAREAN SECTION; CHILD; CHILD HOSPITALIZATION; COHORT ANALYSIS; DANISH CITIZEN; DAY CARE; FEMALE; GENDER; GESTATIONAL AGE; HUMAN; INFECTION RISK; MALE; MATERNAL AGE; MATERNAL SMOKING; PARENTHOOD; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK ASSESSMENT; RISK FACTOR; SIBLING; SMALL FOR DATE INFANT; DENMARK; HEALTH SURVEY; HOSPITALIZATION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; REGISTER; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIROLOGY;

CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PATIENT OUTCOME ASSESSMENT; POPULATION SURVEILLANCE; REGISTRIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS;

EID: 84944345736     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000924     Document Type: Article

References (41)

1. Simoes EA., Respiratory syncytial virus infection. Lancet 1999 354 847 852
2. Boyce TG, Mellen BG, Mitchel EF Jr, Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000 137 865 870
3. Eriksson M, Bennet R, Rotzén-Ostlund M, Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 2002 91 593 598
4. Bonnet D, Schmaltz AA, Feltes TF., Infection by the respiratory syncytial virus in infants and young children at high risk. Cardiol Young 2005 15 256 265
5. Meissner HC, Rennels MB, Pickering LK, Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab. Pediatr Infect Dis J 2004 23 284 285
6. Kristensen K, Hjuler T, Ravn H, Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis 2012 54 810 817
7. Murray J, Bottle A, Sharland M, Medicines for Neonates Investigator Group Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS One 2014 9 e89186
8. Knudsen LB, Olsen J., The Danish Medical Birth Registry. Dan Med Bull 1998 45 320 323
9. Andersen TF, Madsen M, Jørgensen J, The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999 46 263 268
10. Kildemoes HW, Sørensen HT, Hallas J., The Danish National Prescription Registry. Scand J Public Health 2011 39 7 suppl 38 41
11. Stensballe LG, Kristensen K, Nielsen J, Diagnosis coding in the Danish National Patient Registry for respiratory syncytial virus infections. Scand J Infect Dis 2005 37 747 752
12. Kamper-Jørgensen M, Wohlfahrt J, Simonsen J, The Childcare Database: a valuable register linkage. Scand J Public Health 2007 35 323 329
13. Thygesen L., The register-based system of demographic and social statistics in Denmark. Stat J UN Econ Comm Eur 1995 12 49 55
14. Pedersen CB, Gøtzsche H, Møller JO, The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006 53 441 449
15. Marsál K, Persson PH, Larsen T, Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996 85 843 848
16. Sommer C, Resch B, Simões EA., Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 2011 5 144 154
17. Sampalis JS, Langley J, Carbonell-Estrany X, Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation. Med Decis Making 2008 28 471 480
18. Carbonell-Estrany X, Figueras-Aloy J, Law BJ, Infección Respiratoria Infantil por Virus Respiratorio Sincitial Study Group; Pediatric Investigators Collaborative Network on Infections in Canada Study Group Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings. Pediatr Infect Dis J 2004 23 11 suppl S193 S201
19. Escobar GJ, Masaquel AS, Li SX, Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy. BMC Pediatr 2013 13 97
20. Henderson J, Hilliard TN, Sherriff A, Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005 16 386 392
21. Pedraz C, Carbonell-Estrany X, Figueras-Aloy J, IRIS Study Group Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants. Pediatr Infect Dis J 2003 22 823 827
22. Sigurs N, Aljassim F, Kjellman B, Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010 65 1045 1052
23. Stein RT, Sherrill D, Morgan WJ, Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999 354 541 545
24. Poorisrisak P, Halkjaer LB, Thomsen SF, Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins. Chest 2010 138 338 344
25. Stensballe LG, Simonsen JB, Thomsen SF, The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J Allergy Clin Immunol 2009 123 131 137.e1
26. Thomsen SF, van der Sluis S, Stensballe LG, Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 2009 179 1091 1097
27. Blanken MO, Rovers MM, Molenaar JM, Dutch RSV Neonatal Network Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013 368 1791 1799
28. Simoes EA, Groothuis JR, Carbonell-Estrany X, Palivizumab Long-Term Respiratory Outcomes Study Group Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr 2007 151 34 42, 42.e1
29. Yoshihara S, Kusuda S, Mochizuki H, C-CREW Investigators Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. Pediatrics 2013 132 811 818
30. Ambrose CS, Anderson EJ, Simões EA, Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J 2014 33 576 582
31. Cilla G, Sarasua A, Montes M, Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain. Epidemiol Infect 2006 134 506 513
32. Nielsen HE, Siersma V, Andersen S, Respiratory syncytial virus infection-risk factors for hospital admission: a case-control study. Acta Paediatr 2003 92 1314 1321
33. Liu X, Olsen J, Agerbo E, Birth weight, gestational age, fetal growth and childhood asthma hospitalization. Allergy Asthma Clin Immunol 2014 10 13
34. Paranjothy S, Dunstan F, Watkins WJ, Gestational age, birth weight, and risk of respiratory hospital admission in childhood. Pediatrics 2013 132 e1562 e1569
35. Simoes EA., Respiratory syncytial virus infection. Lancet 1999 354 847 852
36. Corsi DJ, Boyle MH, Lear SA, Trends in smoking in Canada from 1950 to 2011: progression of the tobacco epidemic according to socioeconomic status and geography. Cancer Causes Control 2014 25 45 57
37. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, IRIS Study Group FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 2008 27 788 793
38. Simões EA, Carbonell-Estrany X, Fullarton JR, European RSV Risk Factor Study Group A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study. Respir Res 2008 9 78
39. Mosalli R, Abdul Moez AM, Janish M, Value of a risk scoring tool to predict respiratory syncytial virus disease severity and need for hospitalization in term infants. J Med Virol 2015 87 1285 1291
40. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014 134 415 420
41. Schützle H, Weigl J, Puppe W, Diagnostic performance of a rapid antigen test for RSV in comparison with a 19-valent multiplex RT-PCR ELISA in children with acute respiratory tract infections. Eur J Pediatr 2008 167 745 749